Line 25: |
Line 25: |
| * Active aginst many gram negatives. ''Pseudomonas'' species are resistant. | | * Active aginst many gram negatives. ''Pseudomonas'' species are resistant. |
| | | |
− | '''Second Generation Cephalosporins''' - Ceftiofur | + | '''Second Generation Cephalosporins''' - Cefuroxime |
| * Very broad spectrum with very high activity against enterobacteriaeceae. | | * Very broad spectrum with very high activity against enterobacteriaeceae. |
| * Struggle against the most difficult gram negative organisms | | * Struggle against the most difficult gram negative organisms |
| | | |
− | '''Third Generation Cephalosporins''' - Cefoperazone | + | '''Third Generation Cephalosporins''' - Cefoperazone, Ceftiofur |
| * Very active against gram negatives, especially the hardier species, including ''Pseudomonas'' | | * Very active against gram negatives, especially the hardier species, including ''Pseudomonas'' |
| * Less active against gram positives compared to other cephalosporins; Staphylococci and enterococci can be resistant. | | * Less active against gram positives compared to other cephalosporins; Staphylococci and enterococci can be resistant. |
Line 35: |
Line 35: |
| '''Fourth Generation Cephalosporins''' - Cefquinome | | '''Fourth Generation Cephalosporins''' - Cefquinome |
| * Very broad spectrum, only the very hardiest of gram negatives aren't susceptible. It is still active againts ''Pseudomonas''. | | * Very broad spectrum, only the very hardiest of gram negatives aren't susceptible. It is still active againts ''Pseudomonas''. |
− |
| |
| | | |
| ==Pharmacokinetic Considerations== | | ==Pharmacokinetic Considerations== |